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Abstract 
Background: Oral squamous cell carcinoma (OSCC) is one of the most important types of oral malignancies. 
DKK gene family members as well as DKK2/4 have critical roles in regulation of Wnt signaling as one of the 
main determining pathway in oral carcinogenesis. This study aimed to identify promoter methylation status of 
DKK2/4 genes to provide possible biomarkers for early detection and treatment of OSCC patients. 
Methods: A case control study was performed on 31 fresh tissues obtained from oral cavity of patients affect-
ed by OSCC and 31 fresh corresponding tissues from normal healthy controls in Tehran and, between the 
years of 2016-2018. Purified DNA from tissue samples was subjected to bisulfite treatment and then methyla-
tion specific polymerase chain reaction (MSP-PCR) was carried out on treated DNA samples. 
Results: DKK4 promoter was methylated in none of OSCC samples while it was methylated in 16.1% of 
healthy controls. 16.1% of OSCC samples were detected to be semimethylated and 22.6% of healthy normal 
samples were methylated for DKK2 promoter gene. Meaningful difference was found in DKK4 promoter 
methylation among OSCC patients and healthy controls. Significant correlation was found between DKK4 
promoter methylation and tumor grade. The age of all enrolled samples was demonstrated to have strong ef-
fect on promoter methylation of studied genes. 
Conclusion: Hypomethylation of DKK2 and DKK4 genes in higher grades of OSCC samples may indicate the 
pivotal role of their expression in tumor cells invasion and progression through modulation of Wnt signaling 
pathway. Further study required to determine simultaneous expression of those genes and Wnt signaling ele-
ments at mRNA and protein levels. 
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Introduction 
 
Oral squamous cell carcinoma (OSCC) is the 
most frequent type of oral cancer and includes 
the major classification of head and neck squa-
mous cell cancer (HNSCC) with relatively low 
survival rate and poor prognosis, The rate of 
OSCC was higher in males and it has higher inci-
dence in South-Central Asia, Central and Eastern 
Europe, One of the amazing features of OSCC is 
that both endogenous and exogenous environ-
mental factors have crucial roles in carcinogenesis 
process. Smoking and drinking alcohol and be-
come infected with Epstein–Barr virus (EBV) 
and human papillomavirus (HPV) are most im-
portant external risk factors of OSCC, Defining 
the mechanism behind the interaction between 
environmental and endogenous risk factors not 
only could pave the way toward targeted preven-
tion and treatment of OSCC but also provide a 
very earlier screening tests in high risk groups. In 
this way, determining the genetic and epigenetic 
profile of tumor tissues in different stages and 
grade can help to describe the effect of environ-
mental factors on carcinogenesis process.  
 DNA methylation is one of the main mechanism 
of epigenetics which can occur within the promot-
er or body of genes and thereby play a critical role 
in regulation of gene transcription and expression, 
5-methylcytosine which is the most frequent 
product of DNA methylation process can be usu-
ally detected within the cytosine–guanosine dinu-
cleotides (CpGs) lied in GC rich genomic regions 
called as CpG islands. CpG islands can be mostly 
found within or next to the promoter sequence 
and their methylation status can indirectly affect 
the transcription efficacy. CpG islands hypermeth-
ylation is a main cellular defense mechanism 
against cancer through stabilization of oncogenes 
and transposons to be untranscribed and silenced, 
In the other hand, unmethylation of genes which 
are needed to be actively expressed as well as tu-
mor suppressor or germ cells is a typical expected 
feature of tumor suppressor genes. The reverse 
pattern of methylation in either oncogenes or tu-
mor suppressor genes may indicate the role of 
those genes in the carcinogenesis process. 
Dickkopf (DKK) is a gene family comprising for 
members (DKK1-4) which share common con-
served cystein rich protein domain. The general 
role of this glycoprotein family specifically 
DKK1/2/4 has been determined as inhibitors of 
Wnt/ β-catenin pathway which has critical role in 
embryonic development, cell proliferation and 
migration, However, the activators effect of 
DKK2 on Wnt signaling has been demonstrated 
as much as its inhibitory action, Given that Wnt 
signaling pathway is a double edged sword in 
cancer progression, the exact role of DKK family 
in carcinogenesis has been remained unclear, as 
well. Moreover, some of this family members as 
well as DKK2 and DKK1 can function inde-
pendent of β-catenin and enhance apoptosis pro-
cess, What is interesting about DKK1 and maybe 
DKK2 is that unlike other Wnt antagonists, 
DKK1 overexpression has shown to have target-
ed specific suppressing effect on Wnt signaling 
pathway, Owing to this specific effect and some 
reports indicating hypermethylation of other Wnt 
pathway antagonists as well as secreted frizzled-
related protein (sFRP) in other cancers, we aimed 
to determine the methylation pattern of DKK2 
and DKK4 promoter genes which their role and 
action are less clear, 
 
Materials and Methods 
 
Sample preparation 
Sixty two fresh tissue samples were obtained 
from oral cavity of 31 healthy and 31 patients 
affected by OSCC and stored in -80 °C until fur-
ther assessments. The study was performed in a 
case control design in Tehran and, between the 
years of 2016-2018. Sample size was calculated 
using Minitab sample size calculator software by 
consideration of α=0.05, β= 0.2, d=0.15 and 
P=0.3 and it was based on previous report, as 
well, Design of study was as case control in 
which normal control samples were collected 
from individuals reffered for cosmetic perio-
dentic surgeries such as increasing the length of 
dental crown whom had no medical or familial 
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history of cancer and were healthy. Every pa-
tients whom undergone either chemotherapy or 
radiotherapy besides tumour tissues which were 
related to extra oral or posterior oral cavity tis-
sues were excluded from study. Inclusion criteria 
were having pathology confirmation of normal 
and OSCC and age range of 20-90 yr old.  
Consent form was filled for all the enrolled pa-
tients and healthy controls according to the local 
Ethics Committee of Tehran University of Medi-
cal Sciences, School of Dentistry (Date of Ap-
proval: 20.11.2015. Approval number: 29-08-
1394) and ethical standards of the Helsinki Dec-
laration, as revised in 2013 (available at 
http://www.wma.net/en/30publications/10polic
ies/b3/), as well. 
DNA isolation and modification 
DNA was purified from all the samples using 
QIAamp DNA Mini Kit (Qiagen) and then sub-
jected to treatment with DNA bisulfite kit (EZ 
DNA Methylation-Gold™ Kit, USA) to convert 
the unmethylated cytosine into uracil within the 
promoters of two DKK2 and DKK4 genes. The 
purity and quantity of obtained DNAs were ex-
amined by NanoDrop ND-1000 spectrophotom-
eter (NanoDrop Technologies, Wilmington, DE).  
Promoter Methylation Analysis 
The modified DNA sequences were amplified 
using two primer pairs designed for each methyl-
ated or unmethylated templates of DKK2 and 
DKK4 genes in methylation specific PCR (MSP). 
Primer pair sequences were retrieved from previ-
ous report and were confirmed on Methprimer 
website (Table 1). 
 
Table 1: Primer pairs sequences of Methylated and unmethylated PCR reactions 
 
Gene DKK2 DKK4 
Unmethylated pri-
mer pair sequences 
Forward: 
5′-TGTTTTTTAGGTATTGTTGTGTTGGTAGT-3′ 
Reverse: 
5′-ATAAAAAATCAAAAAACATCCCCAAACCA-3′ 
Forward: 
5′-AGAAAAAGTAGTGATAAATAGACGACG-3′ 
Reverse: 
5′-CAACACTATACATCACCAAAACAAA-3′ 
Methylated primer 
pair sequences 
Forward: 
5′-TTTTTAGGTATCGTTGCGTTGGTAGC-3′ 
Reverse: 
5′-AAAATCAAAAAACGTCCCCGAACCG-3′ 
Forward: 
5′-AGAAAAAGTAGTGATAAATAGACGACGT-3′ 
Reverse: 
5′-CAACACTATACGTCACCAAAACGAA-3′ 
 
The PCR reaction for each of methylated or un-
methylated PCRs included 10 pmol of each for-
ward and reverse primers specific for methylated 
or unmethylated sequences, 2.5 µl of 10x buffer, 
2 mM of Mgcl2, 0.2 mM of dNTP mixture and 
1U of Hot start Taq DNA polymerase (Fermen-
tase) which was added to 100 ng of each treated 
genomic DNA samples and then adjusted with 
ddH2O. After initial denaturation at 95 °C for 5 
min, forty PCR cycles (95 °C in 30 sec, 30 sec in 
annealing temperature, 72 °C in 30 sec) were car-
ried out and pursued by final extension at 72 °C 
for 5 min. The annealing temperature (Ta) was 
optimized at 58 °C and 51 °C for methylated 
templates amplification of DKK2 and DKK4 
promoter genes, respectively. Ta of unmethylated 
reactions was optimized as 49 °C and 51 °C for 
amplification of DKK4 and DKK2 genes. PCR 
products were then resolved on polyacrylamide 
gel (10%) following AgNo3 staining.  
Statistical analysis 
Data was statistically analyzed with the SPSS 17.0 
(SPSS Inc, IL, USA). Chi-square, Fisher’s exact 
and t- tests were implicated to explore the corre-
lation among various variants of the patients and 
controls. In addition, Mann-whitney U test and 
spearman regression coefficient test were impli-
cated to find the correlation between clinical 
grades and gene methylation. In all of the statisti-
cal analyses, Р- value less than 0<0.05 was con-
sidered as significant. 
 
Results 
 
Four primer pairs were used to amplify the modi-
fied template sequences of DKK2 and DKK4 genes  
(Fig. 1). 
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Fig. 1: Schematic site of the promoter region of DKK2 gene which has been targeted to be amplified following bi-
sufite treatment 
 
The mean of enrolled patients and healthy con-
trols age were 60.81±15.29 and 38.32±15.25, re-
spectively. Distribution of gender of participants 
was calculated as 16 male and 15 female among 
patients and controls.  
DKK4 promoter methylation was not detected in 
no one of OSCC samples while it was methylated 
in 16.1% of healthy controls (Fig. 2,4).  
 
 
 
Fig. 2: A, MSP-PCR products of regarding unmethylated DKK4 gene promoter among OSCC patients and healthy 
controls; B, MSP-PCR products (1-4) of regarding methylated DKK4 gene promoter among healthy controls. M: 
Ladder 50 bps. 
 
Regarding DKK2 gene promoter, 5 OSCC sam-
ples (16.1%) were detected to be semimethylated 
and 7 controls (22.6%) had revealed to be meth-
ylated (Fig. 3,4). 
 
 
Fig. 3: A, MSP-PCR products of regarding unmethylated DKK2 gene promoter among OSCC patients and healthy 
controls; B, MSP-PCR products (1-5) of regarding methylated DKK2 gene promoter among healthy controls. M: 
Ladder 50 bps 
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Fig. 4: Distribution of methylation status of DKK2 and DKK4 genes among cases and controls. 
 
Among semimethylated OSCC samples, 3 and 2 
tissues were classified as tumor with good and 
intermediate differentiation, respectively. Mann-
Whitney U test analysis have demonstrated that 
there was meaningful difference in DKK4 pro-
moter methylation among OSCC patients and 
healthy controls (P=0.02). In contrast of DKK2 
gene, there was significant correlation between 
DKK4 promoter methylation and tumor grade 
(P=0.03). Age of enrolled samples including can-
cer and healthy individuals had strong effect on 
promoter methylation of DKK2 and DKK4 gene 
promoters (P<0.001) 
 
Discussion 
 
DKK4 promoter gene was significantly methylated 
in OSCC samples compared to controls and has 
shown to be more unmthylated in higher grades. 
Promoter methylation of DKK4 and DKK2 genes 
was identified in healthy controls whereas methyl-
ation status of those genes in OSCC samples was 
detected as semimehtylation of only DKK2. It was 
semimethylated in 5 OSCC patients with well and 
moderately differentiated tumor grades while it 
was unmethylated in 77.4% of the healthy con-
trols. Present failure to detect methylation within 
the promoter of either DKK2 or DKK4 genes in 
OSCC tissues may be an enough reason on the 
importance of expression of them in pathogenesis 
of OSCC. However, in the present study, pattern 
of demethylation process would be different ow-
ing to the identification of semimethylated DKK2 
promoter gene in OSCC cases which was signifi-
cantly correlated with age. Although it was previ-
ously shown to be possible as independent event, 
hypomethylation of DKK2 in higher grades of tu-
mor versus semimethylation pattern in low grades 
may be indicating that overexpression of DKK2 
gene is necessary for tumor transition from low to 
high grades. Recently, invasion of tumor cells 
through epithelial mesenchymal transition (EMT) 
is dependent on a dynamic methylation transition 
in some genes toward hypomethylation and in 
some other towards hyper methylation. Herein, 
although the number of identified samples was 
low, age dependent methylation of DKK4 gene in 
younger healthy individuals would be a further 
confirmation on this fact that DKK4 may play as 
oncogene and should be suppressed in normal 
non-cancerous status. 
Among Dickkopf family, DKK3 gene and protein 
expression have been shown to be increased in 
higher grades of OSCC tumors and head and neck 
squamous cell carcinoma cells and the cellular 
localization of protein has been changed, as well. 
Although the mRNA and protein expression of 
DKK2 and DKK4 genes were not analyzed in the 
present study, based on the reverse correlation 
between gene methylation and expression they 
presumably enroll in the same direction toward 
OSCC formation and invasion as much as DKK3. 
However, expression of genes could be regulated 
independent of methylation status and regardless 
of unmethylated promoter may be decreased 
through other mechanism of transcription 
modulations as well as microRNAs (miRNAs), 
Overexpression of DKK2 gene have been found in 
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prostate cancer, medulloblastoma, However, the 
scenario may be different in higher grades of 
various other human cancers as well as colorectal 
cancer, renal cell carcinoma (RCC) and ovarian 
cancer in which DKK2 has been shown to be 
methylated in cancer cell line and identified as 
tumor suppressor gene, In contrast, DKK4 gene 
overexpression has demonstrated in 
meduloblastoma and its overexpression was found 
to be correlated with higher rate of invasion and 
proliferation of colorectal cancer cells which could 
be in line with promoter hypomethylation of our 
OSCC samples. However, DKK4 expression was 
shown to be associated with decrease in hepatoma 
cells progression induced by thyroid hormones 
and has been marked as tumor suppressor gene in 
hepatocellular carcinoma. Based on the 
aforementioned studies, except of prostate cancer, 
overexpression pattern of DKK2 and DKK4 genes 
which could be consistent with our finding 
regarding promoter hypomethylation in higher 
grades of OSCC tumor tissues may be restricted to 
head cancers category. In the other hand, defining 
the exact role of Wnt pathway as proliferative or 
antiproliferative signaling modules can clarify the 
possible character of DKK2 and DKK4 genes as 
weather they are tumor suppressor genes or 
oncogenes in pathogenesis of OSCC.  
 
Conclusion 
 
Hypomethylation of DKK2 and DKK4 genes in 
higher grades of OSCC tissue samples may 
indicating their overexpression and thereby tumor 
progression through suppressing Wnt pathway. By 
revealing the gene and protein expression pattern 
of those genes in OSCC samples in further study, 
the exact role of Wnt signaling would be identified 
to be as OSCC driver or suppressor. Moreover, 
finding correlation among DKK2 promoter 
methylation, its expression pattern and their 
correlation with Wnt signaling pathway members 
are warranted to define the behavior of DKK2 as 
inducer or inhibitor of Wnt pathway in OSCC 
pathogenesis. 
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